Hypoglycemia but Not Hyperglycemia Is Associated with Mortality in Critically Ill Patients with Diabetes.
Critically ill patients
Glucose
Glucose deviation
Hypoglycemia
Intensive care unit
Stress hyperglycemia
Journal
Medical principles and practice : international journal of the Kuwait University, Health Science Centre
ISSN: 1423-0151
Titre abrégé: Med Princ Pract
Pays: Switzerland
ID NLM: 8901334
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
12
2017
accepted:
13
12
2018
pubmed:
14
12
2018
medline:
9
6
2020
entrez:
14
12
2018
Statut:
ppublish
Résumé
Both severe hyperglycemia (> 200 mg/dL) and hypoglycemia (≤70 mg/dL) are known to be associated with increased mortality in critically ill patients. Therefore, we investigated associations of a single episode of blood glucose deviation (concentration either ≤70 mg/dL and/or > 200 mg/dL) during an intensive care unit (ICU) stay with mortality in these patients. A total of 4,986 patients (age 65 ± 15 years; 39% female; 14% type 2 diabetes [T2DM] based on medical records) admitted to a German ICU in a tertiary care hospital were investigated retrospectively. The intra-ICU and long-term mortality of patients between 4 and 7 years after their ICU submission were assessed. A total 62,659 glucose measurements were analyzed. A single glucose deviation was associated with adverse outcomes compared to patients without a glucose deviation, represented by both intra-ICU mortality (22 vs. 10%; OR 2.62; 95% CI 2.23-3.09; p < 0.001) and long-term mortality (HR 2.01; 95% CI 1.81-2.24; p < 0.001). In patients suffering from T2DM hypoglycemia (30 vs. 13%; OR 2.94; 95% CI 2.28-3.80; p < 0.001) but not hyperglycemia (16 vs. 14%; OR 1.05; 95% CI 0.68-1.62; p = 0.84) was associated with mortality. In patients with dia-betes, hypo- but not hyperglycemia was associated with increased mortality, whereas in patients without diabetes, both hyper- and hypoglycemia were associated with adverse outcome. Blood glucose concentration might need differential approaches depending on concomitant diseases.
Sections du résumé
BACKGROUND
Both severe hyperglycemia (> 200 mg/dL) and hypoglycemia (≤70 mg/dL) are known to be associated with increased mortality in critically ill patients. Therefore, we investigated associations of a single episode of blood glucose deviation (concentration either ≤70 mg/dL and/or > 200 mg/dL) during an intensive care unit (ICU) stay with mortality in these patients.
METHODS
A total of 4,986 patients (age 65 ± 15 years; 39% female; 14% type 2 diabetes [T2DM] based on medical records) admitted to a German ICU in a tertiary care hospital were investigated retrospectively. The intra-ICU and long-term mortality of patients between 4 and 7 years after their ICU submission were assessed.
RESULTS
A total 62,659 glucose measurements were analyzed. A single glucose deviation was associated with adverse outcomes compared to patients without a glucose deviation, represented by both intra-ICU mortality (22 vs. 10%; OR 2.62; 95% CI 2.23-3.09; p < 0.001) and long-term mortality (HR 2.01; 95% CI 1.81-2.24; p < 0.001). In patients suffering from T2DM hypoglycemia (30 vs. 13%; OR 2.94; 95% CI 2.28-3.80; p < 0.001) but not hyperglycemia (16 vs. 14%; OR 1.05; 95% CI 0.68-1.62; p = 0.84) was associated with mortality.
CONCLUSION
In patients with dia-betes, hypo- but not hyperglycemia was associated with increased mortality, whereas in patients without diabetes, both hyper- and hypoglycemia were associated with adverse outcome. Blood glucose concentration might need differential approaches depending on concomitant diseases.
Identifiants
pubmed: 30544102
pii: 000496205
doi: 10.1159/000496205
pmc: PMC6545909
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
186-192Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2018 The Author(s) Published by S. Karger AG, Basel.
Références
Crit Care. 2013 Mar 01;17(2):R37
pubmed: 23452622
Crit Care. 2008;12(5):R120
pubmed: 18799004
Nature. 2001 Dec 13;414(6865):813-20
pubmed: 11742414
J Diabetes Sci Technol. 2009 Nov 01;3(6):1242-9
pubmed: 20144377
Crit Care Med. 1981 Aug;9(8):591-7
pubmed: 7261642
J Crit Care. 2012 Apr;27(2):153-8
pubmed: 21855283
N Engl J Med. 2009 Mar 26;360(13):1283-97
pubmed: 19318384
Curr Vasc Pharmacol. 2016;14(2):155-62
pubmed: 26638796
Am J Cardiol. 2012 Jan 1;109(1):53-9
pubmed: 21944676
Crit Care Med. 2016 Jul;44(7):1338-46
pubmed: 26958752
J Diabetes Complications. 2015 Nov-Dec;29(8):1130-5
pubmed: 26361811
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Ann Intensive Care. 2016 Dec;6(1):115
pubmed: 27878572
Curr Opin Crit Care. 2014 Oct;20(5):557-65
pubmed: 25137401
Mayo Clin Proc. 2003 Dec;78(12):1471-8
pubmed: 14661676
Int J Cardiol. 2010 Sep 3;143(3):368-72
pubmed: 19398138
J Thorac Dis. 2016 Jul;8(7):E621-4
pubmed: 27501420
Intensive Care Med. 2009 Oct;35(10):1738-48
pubmed: 19636533
Crit Care. 2012 Oct 12;16(5):R189
pubmed: 23062226
Crit Care. 2010;14(4):231
pubmed: 20727232
Diabetologia. 2009 Jan;52(1):42-5
pubmed: 18972096
Best Pract Res Clin Endocrinol Metab. 2011 Oct;25(5):825-34
pubmed: 21925081
Int J Mol Sci. 2016 Sep 21;17(9):
pubmed: 27657056
Diabetologia. 2006 Aug;49(8):1722-5
pubmed: 16758178
Lancet. 2009 May 23;373(9677):1798-807
pubmed: 19465235
Am J Med. 2014 Oct;127(10 Suppl):S17-24
pubmed: 25282009
J Clin Invest. 2013 Nov;123(11):4888-99
pubmed: 24135141
Clin Hemorheol Microcirc. 2015;61(2):213-24
pubmed: 26410873
Crit Care Med. 2010 Jun;38(6):1430-4
pubmed: 20386307
J Crit Care. 2014 Dec;29(6):1052-6
pubmed: 25092614